2022
Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses
Wisnewski AV, Liu J, Lucas C, Klein J, Iwasaki A, Cantley L, Fazen L, Luna J, Slade M, Redlich CA. Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses. PLOS ONE 2022, 17: e0262657. PMID: 35041700, PMCID: PMC8765639, DOI: 10.1371/journal.pone.0262657.Peer-Reviewed Original ResearchConceptsPlaque reduction neutralization testCOVID-19 patientsVaccine responsesRecovered COVID-19 patientsSARS-CoV-2 immunityBooster vaccine dosesMRNA vaccine responsePost-vaccine seraCompetitive ELISAEnzyme 2 (ACE2) receptorReduction neutralization testType of vaccineSARS-CoV-2 spike protein receptorSpike protein receptorVaccine seraVaccine recipientsPost vaccinationVaccinated individualsVaccine dosesViral culturePrior historyViral neutralizationNeutralization testBooster shotsPost vaccine
2021
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain
Bayarri-Olmos R, Idorn M, Rosbjerg A, Pérez-Alós L, Hansen C, Johnsen L, Helgstrand C, Zosel F, Bjelke J, Öberg F, Søgaard M, Paludan S, Bak-Thomsen T, Jardine J, Skjoedt M, Garred P. SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain. The Journal Of Immunology 2021, 207: 878-887. PMID: 34301847, DOI: 10.4049/jimmunol.2100272.Peer-Reviewed Original ResearchMeSH KeywordsAngiotensin-Converting Enzyme 2AnimalsAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralAntigens, ViralCoronavirus Nucleocapsid ProteinsCOVID-19COVID-19 SerotherapyCOVID-19 VaccinesEnzyme-Linked Immunosorbent AssayHumansImmunizationImmunization, PassiveImmunoglobulin AImmunoglobulin GImmunoglobulin MMiceNeutralization TestsProtein DomainsReceptors, VirusSARS-CoV-2Spike Glycoprotein, CoronavirusConceptsPlaque reduction neutralization testReceptor-binding domainReduction neutralization testNeutralization testFull-length spike proteinSARS-CoV-2 transmissionSARS-CoV-2 receptor-binding domainViral neutralization testSARS-CoV-2Levels of AbsIgG titersVaccine strategiesAntibody responsePreclinical modelsConvalescent seraImmune responseMouse modelNeutralization potencyVirus neutralizationFull spikesImmunization strategiesMurine mAbsImmunization resultsSpike proteinELISASocial determinants associated with Zika virus infection in pregnant women
Nery N, Ticona J, Gambrah C, Doss-Gollin S, Aromolaran A, Rastely-Júnior V, Lessa M, Sacramento GA, Cruz JS, de Oliveira D, dos Santos LL, da Silva CG, Botosso VF, Soares CP, Araujo DB, Oliveira DB, dos Santos Alves RP, Andreata-Santos R, Durigon EL, de Souza Ferreira LC, Wunder EA, Khouri R, Oliveira-Filho J, de Siqueira IC, Almeida ARP, Reis MG, Ko AI, Costa F. Social determinants associated with Zika virus infection in pregnant women. PLOS Neglected Tropical Diseases 2021, 15: e0009612. PMID: 34329305, PMCID: PMC8323902, DOI: 10.1371/journal.pntd.0009612.Peer-Reviewed Original ResearchConceptsPregnant womenSocial determinantsZIKV exposureZIKV infectionZika virusPlaque reduction neutralization testReferral maternity hospitalZika virus infectionReduction neutralization testCross-sectional studyKey social determinantsZIKV resultsClinical characteristicsMaternity hospitalRisk factorsVirus infectionExposure statusSociodemographic determinantsNeutralization testMultivariate analysisInfection riskLogistic regressionLower educationFuture interventionsInfection
2020
Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine
Anderson EJ, Lai L, Wrammert J, Kabbani S, Xu Y, Priyamvada L, Hill H, Goll JB, Jensen TL, Kao C, Yildirim I, Rouphael N, Jackson L, Mulligan MJ. Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine. Vaccines 2020, 8: 69. PMID: 32041104, PMCID: PMC7158692, DOI: 10.3390/vaccines8010069.Peer-Reviewed Original ResearchMemory B cellsPlaque reduction neutralization testVaccinia Ankara vaccineCD4 T cellsT cellsB cellsDay 1Follicular helper T cell responsesIgG-secreting B cellsModified Vaccinia Ankara VaccineFollicular helper T cellsHelper T cell responsesVaccinia-specific antibodiesT cell responsesHelper T cellsReduction neutralization testEnzyme-linked immunosorbentSecond vaccineEvaluable specimensInjection recipientsPRNT titersDay 29Neutralization testPlasmablastsNovel vaccines
1998
Epidemiology of endemic Oropouche virus transmission in upper Amazonian Peru.
Baisley K, Watts D, Munstermann L, Wilson M. Epidemiology of endemic Oropouche virus transmission in upper Amazonian Peru. American Journal Of Tropical Medicine And Hygiene 1998, 59: 710-6. PMID: 9840586, DOI: 10.4269/ajtmh.1998.59.710.Peer-Reviewed Original ResearchConceptsAntibody prevalenceLife-long residentsIgG antibodiesViral infectionStandard plaque reduction neutralization testPlaque reduction neutralization testWald chi-squareCross-sectional serosurveyHalf of personsVenous blood samplesRisk factor dataMultiple logistic regressionAge five yearsYears of ageSeropositive residentsSerologic statusRisk factorsViral antibodiesBlood samplesNeutralization testAntibody reactivityHuman infectionsORO virusLogistic regressionEndemic transmission
1994
Restriction endonuclease analysis of adenovirus isolates from sporadic and epidemic ocular infections: experience in a clinical laboratory
Mahafzah A, Landry ML. Restriction endonuclease analysis of adenovirus isolates from sporadic and epidemic ocular infections: experience in a clinical laboratory. Journal Of Medical Microbiology 1994, 40: 385-388. PMID: 8006929, DOI: 10.1099/00222615-40-6-385.Peer-Reviewed Original Research
1991
Human-rodent contact and infection with lymphocytic choriomeningitis and Seoul viruses in an inner-city population.
Childs J, Glass G, Ksiazek T, Rossi C, Oro J, Leduc J. Human-rodent contact and infection with lymphocytic choriomeningitis and Seoul viruses in an inner-city population. American Journal Of Tropical Medicine And Hygiene 1991, 44: 117-21. PMID: 1672798, DOI: 10.4269/ajtmh.1991.44.117.Peer-Reviewed Original ResearchConceptsLymphocytic choriomeningitis virusSeoul virusRodent-borne virusesHuman-rodent contactHistory of travelInner-city populationDisease clinicRodent exposureLymphocytic choriomeningitisAntibody prevalenceNeutralization testSerological testsAntibodiesVirusHigh rateInfectionRatsMore exposureExposureQuestionnaire responsesChoriomeningitisClinicPrevalenceMicePersons
1986
Global survey of antibody to Hantaan-related viruses among peridomestic rodents.
LeDuc J, Smith G, Childs J, Pinheiro F, Maiztegui J, Niklasson B, Antoniades A, Robinson D, Khin M, Shortridge K. Global survey of antibody to Hantaan-related viruses among peridomestic rodents. Bulletin Of The World Health Organization 1986, 64: 139-44. PMID: 2425998, PMCID: PMC2490912.Peer-Reviewed Original ResearchConceptsHantaan-like virusNeutralization testHigher antibody prevalence ratesPlaque reduction neutralization testPrevalence of antibodiesReduction neutralization testAntibody prevalence ratesPrototype Hantaan virusHosts of hantavirusesSpecificity of antibodiesAntibody-positive rodentsPrevalence ratesRenal syndromeHaemorrhagic feverImmunofluorescent antibodyPositive seraHantaan virusPeridomestic rodentsSerological surveyRodent seraAntibodiesHantaanSerumCausative agentVirus
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply